SolutionClinical Overview
Minoxidil topical solution (5% w/v) is a vasodilator and hair growth stimulant on the WHO Model List of Essential Medicines. It shortens the telogen (resting) phase, induces early entry into anagen (growth), increases hair follicle diameter, and enhances microvascular blood flow to the follicular papilla. Indicated for the treatment of androgenetic alopecia (pattern baldness) in men and women.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Apply 1 mL twice daily directly onto clean, dry scalp in the hair loss region. Spread gently. Wash hands with soap. Do not blow-dry hair after application. Consistent twice-daily application for at least 4 months is required to assess efficacy; cessation leads to reversal of regrowth within 3 to 4 months.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Scalp irritation, pruritus, dry flakes, temporary increased hair shedding during weeks 2-6, unwanted facial hair growth (hypertrichosis) if solution drips. Rare/Severe: Tachycardia, lightheadedness, chest pain, and peripheral edema (via systemic absorption).
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
For external scalp application only. Flammable; keep away from open flames. Avoid contact with eyes; if contacted, flush with copious cool water. Discontinue if palpitations, fainting, or swelling of hands/feet occur.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered dermatologist or qualified medical practitioner before initiating, altering, or substituting any topical or systemic dermatological treatment.
Biotin Tablets 10mg
Biotin Tablets 10mg is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.
Finasteride Tablets 5mg
Finasteride Tablets 5mg is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.
Minoxidil 5% and Finasteride 0.1% Topical Solution
Minoxidil (5%) and Finasteride (0.1%) topical solution is an advanced dual-action therapy for male androgenetic alopecia (male pattern baldness). Minoxidil stimulates dermal papilla vascular endothelial growth factor (VEGF), opens potassium channels, and prolongs the anagen (growth) phase of hair follicles, while topical finasteride selectively inhibits type II 5-alpha reductase in the scalp, lowering local dihydrotestosterone (DHT) levels by up to 70% with substantially less systemic exposure than oral finasteride. Indicated for male androgenetic alopecia of the vertex and anterior scalp.
Finasteride Tablets 1mg
Finasteride Tablets 1mg is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.